This website will not work correctly in Internet Explorer 11 and it is strongly recommended that you upgrade to an up-to-date browser. Internet Explorer 11 will go out of support and be retired on June 15, 2022. For more information on upgrading please see browser-update.org.
Jeremy Farrar, Wellcome's Director, pays tribute to Dr Peter Salama, an Executive Director at the WHO who was instrumental in leading efforts to tackle Ebola.
A class of antiretroviral drugs commonly used to treat HIV, particularly in Africa and low-income countries, can cause premature ageing, according to research published today…
Interim results from the Guinean phase III trial of the Ebola vaccine known as VSV-EBOV, co-funded by the Wellcome Trust, indicate that it is highly effective against the…
We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, global heating and infectious diseases.…
Henry Wellcome (1853-1936) was a pharmaceutical entrepreneur. He left us three things in his will: his wealth, his collection of historical medical items, and a mission to…
As we'll soon start to see the results of the first vaccines coming through late-stage clinical trials, Jeremy Farrar explains why we should be cautiously optimistic.
This statement outlines Wellcome’s approach to maximising access to healthcare interventions for people worldwide, with a focus on low- and middle-income countries (LMICs).
A framework to guide teams building a databank. We provide mitigation strategies that take into account the key ethical considerations associated with building and running a…